pMXs-IP-mVenus-TOSI Citations (1)

Originally described in: Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML.
Oki T, Mercier F, Kato H, Jung Y, McDonald TO, Spencer JA, Mazzola MC, van Gastel N, Lin CP, Michor F, Kitamura T, Scadden DT Nat Commun. 2021 Jan 11;12(1):245. doi: 10.1038/s41467-020-20491-8. PubMed Journal

---

Articles Citing pMXs-IP-mVenus-TOSI

Articles
PDCD4 as a marker of mTOR pathway activation and therapeutic target in mycobacterial infections. Paroha R, Wang J, Lee S. Microbiol Spectr. 2024 Aug 6;12(8):e0006224. doi: 10.1128/spectrum.00062-24. Epub 2024 Jun 24. PubMed

If you have published an article using this material, please email us at to have your article added to this page.